Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

McMaster University

$240,400.00

Point of Care Device for Rapid Quantification of Cell-Free DNA with Application in Severe Sepsis

EF 2015-16

Résumé
Sepsis, the whole body response to infection, is associated with a high risk of intensive care unit admission, organ damage and death. Our clinical work has demonstrated that free DNA (cfDNA) released from cells into the bloodstream is a very strong predictor of ICU death. The current technology to measure DNA requires several hours, at least 5 ml of blood, and uses instruments no longer available in the hospital laboratory. We have developed a device that can measure cfDNA from a small drop of blood. We have completed preliminary tests that demonstrate we can obtain similar results with this prototype device compared to our standard technique. This proposal brings together bioengineers with experience in microfluidic devices that can capture small molecules like DNA, with health research scientists, physicians and clinical biochemists. We are collaborating with a technology company and with our leading practice academic hospital to develop this technology into a small device that could be used at the bedside in minutes to predict who is at greatest risk when presenting with an infection. This device has the potential to improve the recognition and care of the 100,000 Canadians each year that present with sepsis.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
336652
Name
Fox-Robichaud Alison E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Point of Care Device for Rapid Quantification of Cell-Free DNA with Application in Severe Sepsis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$240,400
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Biomedical Engineering 1102; Biomedical Technology 1901; Cell Free Dna; Medical And Health Sciences 1211; Microfluidics; Nucleic Acid 5402; Point Of Care Device; Prognosis; Sepsis; Whole Blood
Abstract
Sepsis, the whole body response to infection, is associated with a high risk of intensive care unit admission, organ damage and death. Our clinical work has demonstrated that free DNA (cfDNA) released from cells into the bloodstream is a very strong predictor of ICU death. The current technology to measure DNA requires several hours, at least 5 ml of blood, and uses instruments no longer available in the hospital laboratory. We have developed a device that can measure cfDNA from a small drop of blood. We have completed preliminary tests that demonstrate we can obtain similar results with this prototype device compared to our standard technique. This proposal brings together bioengineers with experience in microfluidic devices that can capture small molecules like DNA, with health research scientists, physicians and clinical biochemists. We are collaborating with a technology company and with our leading practice academic hospital to develop this technology into a small device that could be used at the bedside in minutes to predict who is at greatest risk when presenting with an infection. This device has the potential to improve the recognition and care of the 100,000 Canadians each year that present with sepsis.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Fox-Robichaud, Alison E; Selvaganapathy, Ponnambalam R
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $240,400~ $0~